ClinicalTrials.Veeva

Menu

Electromyographic Assessment of Sleep Bruxism in Patients With Stage III and IV Periodontitis

U

University of Siena

Status

Completed

Conditions

Periodontitis
Bruxism
Sleep Bruxism

Treatments

Device: Surface Electromyography (dia-BRUXO)

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aims to investigate the association between periodontitis Stage III and IV and the intensity and duration of sleep bruxism episodes. Surface electromyography (EMG) of the masseter muscle will be used to instrumentally assess sleep bruxism in patients with and without periodontal disease

Full description

The purpose of this cross-sectional study is to evaluate whether patients with Stage III and IV periodontitis exhibit differences in sleep bruxism activity compared to individuals without periodontal disease. Participants will undergo comprehensive periodontal assessment and 24-hour EMG recording of the masseter muscle using a portable device. Bruxism activity will be quantified using the Bruxism Work Index (BWI) and Bruxism Time Index (BTI). The study aims to clarify the potential relationship between periodontal inflammation and masticatory muscle activity during sleep, following standardized diagnostic and recording protocols

Enrollment

40 patients

Sex

All

Ages

28 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 28 and 50 years
  • Ability to perform adequate oral hygiene
  • Willingness to participate and sign informed consent
  • For periodontitis group: Diagnosis of Stage III or IV periodontitis
  • For control group: Absence of periodontal disease

Exclusion criteria

  • Use of removable dentures
  • Ongoing orthodontic treatment
  • Temporomandibular disorders (TMD) or orofacial pain
  • Use of medications affecting muscle activity
  • Systemic or psychiatric disorders
  • Diabetes

Trial design

40 participants in 2 patient groups

Periodontitis Group
Description:
Patients diagnosed with Stage III or IV periodontitis according to the 2017 World Workshop classification. Participants will undergo full-mouth periodontal examination and 24-hour surface EMG recording of the masseter muscle to assess sleep bruxism activity.
Treatment:
Device: Surface Electromyography (dia-BRUXO)
Healthy Control Group
Description:
Participants without clinical signs of periodontal disease, matched by age and sex to the periodontitis group. They will also receive a full-mouth periodontal screening and 24-hour surface EMG recording of the masseter muscle for sleep bruxism assessment.
Treatment:
Device: Surface Electromyography (dia-BRUXO)

Trial contacts and locations

1

Loading...

Central trial contact

Nicola Discepoli, DDS, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems